Investigators identified a recurrent mutation at position c.28 in the gene encoding the snRNA U2. This mutation was present in B cell derived tumors, as well as in prostate and pancreatic cancer, suggesting U2 c.28 constitutes a driver candidate associated with worse prognosis.
[NPJ Genomic Medicine]